Development of Therapeutic Agent for Osteoarthritis via Inhibition of KIAA1199 Activity: Effect of Ipriflavone In Vivo

por Zhang, Jiarui, Nishida, Yoshihiro, Koike, Hiroshi, Zhuo, Lisheng, Ito, Kan, Ikuta, Kunihiro, Sakai, Tomohisa, Imagama, Shiro
Publicado 2023

Clinicopathological Role of Serum-Derived Hyaluronan-Associated Protein (SHAP)-Hyaluronan Complex in Endometrial Cancer

por Yabushita, Hiromitsu, Iwasaki, Keita, Kanyama, Kouhei, Obayashi, Yukihiko, Zhuo, Lisheng, Itano, Naoki, Kimata, Koji, Wakatsuki, Akihiko
Publicado 2011

Establishment of a mouse model for injury-induced scar formation and the accompanying chronic pain: Comprehensive microarray analysis of molecular expressions in fibrosis and hyper...

por Li, Yuqiang, Iida, Hiroki, Kimata, Koji, Zhuo, Lisheng, Ota, Akinobu, Kimura, Shinya, Yin, Xiaojian, Deie, Masataka, Ushida, Takahiro
Publicado 2019

Possible Repositioning of an Oral Anti-Osteoporotic Drug, Ipriflavone, for Treatment of Inflammatory Arthritis via Inhibitory Activity of KIAA1199, a Novel Potent Hyaluronidase

por Koike, Hiroshi, Nishida, Yoshihiro, Shinomura, Tamayuki, Ohkawara, Bisei, Ohno, Kinji, Zhuo, Lisheng, Kimata, Koji, Ushida, Takahiro, Imagama, Shiro
Publicado 2022

Conditional knockdown of hyaluronidase 2 in articular cartilage stimulates osteoarthritic progression in a mice model

por Higuchi, Yoshitoshi, Nishida, Yoshihiro, Kozawa, Eiji, Zhuo, Lisheng, Arai, Eisuke, Hamada, Shunsuke, Morita, Daigo, Ikuta, Kunihiro, Kimata, Koji, Ushida, Takahiro, Ishiguro, Naoki
Publicado 2017